SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-015570
Filing Date
2020-07-23
Accepted
2020-07-23 08:50:24
Documents
8
Period of Report
2020-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20200714_8k.htm 8-K 33057
2 EXHIBIT 5.1 ex_194836.htm EX-5.1 11578
3 EXHIBIT 10.1 ex_194837.htm EX-10.1 53274
4 EXHIBIT 99.1 ex_194691.htm EX-99.1 23042
5 EXHIBIT 99.2 ex_194448.htm EX-99.2 888
6 a01.jpg GRAPHIC 58277
7 eximg01.jpg GRAPHIC 2923
8 logo01.jpg GRAPHIC 9001
  Complete submission text file 0001437749-20-015570.txt   220036
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 201042844
SIC: 2834 Pharmaceutical Preparations